Assessment of vitamin D and its association with cardiovascular disease risk factors in an adult migrant population: an audit of patient records at a Community Health Centre in Kensington, Melbourne, Australia by unknown
Ruwanpathirana et al. BMC Cardiovascular Disorders 2014, 14:157
http://www.biomedcentral.com/1471-2261/14/157RESEARCH ARTICLE Open AccessAssessment of vitamin D and its association with
cardiovascular disease risk factors in an adult
migrant population: an audit of patient records
at a Community Health Centre in Kensington,
Melbourne, Australia
Thilanga Ruwanpathirana1, Christopher M Reid1*, Alice J Owen1, David P S Fong2, Usha Gowda3
and Andre M N Renzaho3,4,5Abstract
Background: Vitamin D deficiency is a global public health problem associated with increased risk of cardio-metabolic
diseases and osteoarthritis. Migrants with dark skin settled in temperate climates are at greater risk of both vitamin
D deficiency and cardiovascular diseases. This study aims to identify the risk of vitamin D deficiency and
associations with cardiovascular disease in a migrant population in Australia.
Methods: An audit was carried out at a Community Health Service in Kensington, Melbourne which, services a
large migrant population. Data from the clinical records of all adults who visited the medical centre at least once
during the period from 1st January 2010 to 31st December 2012 was extracted. The future (10 year) coronary heart
disease risk was estimated using Framingham Risk Score.
Results: The centre has given higher priority to vitamin D testing in migrants, those middle-aged, females and
those with diabetes and osteoarthritis. Migrants from countries located in lower latitude regions (Latitude N230 to
S230) were 1.48 (95% C.I. 1.32-1.65) times more likely to develop vitamin D deficiency post migration and 0.44
(95% C.I. 0.31-0.62) times less likely to have a >15% 10-year risk of coronary heart disease when compared to their
Australian-born counterparts.
Conclusions: Adherence to a high risk strategy for vitamin D testing was observed in the centre. Pre-migration
latitude is an important factor for vitamin D deficiency (lower the latitude higher the risk) and in predicting
future risk of cardiovascular disease in migrants. These findings suggest that a targeted approach for vitamin D
testing, including zone of origin might better identify individuals at higher risk of both vitamin D deficiency and
cardiovascular disease.
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Vitamin D deficiency (VDD) has been classified as a
pandemic affecting more than one billion people across all
ages and ethnic groups worldwide [1]. An internationally
standardised cut-off for deficiency is still under debate,
but it is commonly defined as serum 25-hydroxyvitamin
D (25(OH) D) levels less than 50 nmol/L, with levels of
50–75 nmol/L considered as borderline insufficiency [2,3].
There are few rich sources of vitamin D in food and the
main source for humans is the conversion of pro-vitamin
D (7-dehydrocholesterol) to pre-vitamin D3 following skin
exposure to ultraviolet B (UVB) radiation, which is subse-
quently converted to vitamin D3 via a heat dependant
process [4]. Most people can meet their vitamin D needs
through exposure to sunlight [4], however synthesis of
vitamin D varies by colour of the skin (determined by the
amount and type of melanin) in addition to the extent of
exposure.
Despite the fact that Australia has a relatively sunny
climate the prevalence of VDD (mean serum 25(OH)
D < 50 nmol/L) has been estimated as 31% (females -
39% males- 22%) and at high as 50% during winter-spring
[5]. Prevalence of vitamin D insufficiency (VDI) (mean
serum 25(OH) D < 75 nmol/L) was reported to be 73%.
Risk factors identified for VDD in Australia are older age,
female gender, non-European origin, obesity, physical
inactivity and higher level of education. In migrant
populations risk factors included darker skin colour,
Muslim religion, longer length of stay in Australia,
full-covering clothing, decreased daylight exposure,
testing vitamin D levels during winter or spring, living in
an urban environment, coming from a socio-economically
disadvantaged background and being an inpatient or insti-
tutionalised [5-7].
Migrants from low- and middle-income countries,
particularly from South East Asia, the Middle East and
Africa, constitute a significant segment of the Australian
population. The latest Australian census showed that
27% of the resident Australian population was born
overseas, an increase of 23.1% from 2001 [8]. Studies
elucidating the prevalence of VDD among these popula-
tions reported values as high as 88% [9] and an under-
standing of the burden of disease associated with VDD
in these at-risk sub-populations are lacking. Migration
from low- and middle-income countries to industria-
lised countries has been found to be associated with
increased risk of many chronic diseases [10]. While
changes in lifestyles and acculturation are thought to be
significant drivers of chronic disease risk, they do not
solely explain the exponential risk of metabolic diseases
in these sub-populations. It is possible that VDD plays a
role in increasing risk of cardiovascular diseases (CVD).
Darker skin types of the some immigrant populations
while offering protection against the intensity of sunlightin their countries of origin become a risk factor for VDD
when relocating to countries further from the equator
[11]. The origin of migrants could be classified into
three zones according to ability, to synthesize adequate
vitamin D as identified by Arabi et al. [12]. This has been
developed using the country specific vitamin D levels.
 Zone 1 - sufficient Vitamin D production
year-round
(Latitude N23.5° to S23.5°)
 Zone 2 - insufficient Vitamin D production at least
one month/year
(Latitude N23.5° to N48° and > S23.5°)
 Zone 3 - insufficient Vitamin D production most of
the months/year
(Latitude > N48°)
VDD has been long been associated with bone diseases
such as rickets, osteomalacia and osteoporosis, but re-
cent studies also suggest a relationship between VDD
and cardiovascular risk factors [13], including hyper-
tension, diabetes, and metabolic syndromes [14]. What
pre-migration factors influence vitamin D status and
chronic diseases post migration is not clear, however
studies suggest that those who have Vitamin D levels
less than 37 nmol/L and hypertension have double the
risk of developing myocardial infarction, heart failure
or stroke compared to those with Vitamin D levels
more than 37 nmol/L [15].
A number of algorithms for estimating cardiovascular
risk, however the Framingham risk score (FRS) is a widely
accepted method to estimate the risk of coronary heart
disease (CHD) [16]. The method of calculation of FRS is
given in detail elsewhere [17]. FRS has been used in
Australia by the National Vascular Disease Prevention
Alliance to assess the absolute CVD risk [18], and Zomer
and colleagues validated FRS to Australian population by
using a large countrywide sample [19].
With a large and ethnically diverse population living in
Australia, information on CHD risk factors in migrant
sub-groups are limited [20]. Therefore, we hypothesised
that:
 Migrants will be more likely to be tested for vitamin
D than Australian-born residents
 Migrants from sufficient vitamin D zones prior to
migration will be at increased risk of VDD
post-migration
 Migrants from sufficient vitamin D zones prior to
migration will have reduced risk of CHD than
Australian born residents
 VDD will be associated with a higher 10 year
cardiovascular risk, and this association will vary by
migration status
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Setting and data collection
This cross sectional clinical audit was carried out in a
Community Medical Centre in Kensington, Melbourne,
Australia, which services a large migrant population and
has a specific refugee health program. Moonee Valley
and Melbourne City were the two main local govern-
ment areas of this centre, and census data indicate that
in those areas the proportion of residents born overseas
is 28.8% and 49.4% respectively [21,22]. Electronic medical
records were accessed and the most recent laboratory test
results for vitamin D levels, risk factors for CHD, and
demographic data, including migrant status, county of
origin were collected while maintaining patient ano-
nymity. The blood pressure reading of the last visit to the
clinic was used to identify the individuals as hypertensive
(>140/90 mmHg).
Inclusion and exclusion criteria
Adults (19–99 years) (both migrants and non-migrants)
who visited the medical centre at least once during the
period from 1st January 2010 to 31st December 2012 (three
years) were included in the study. The information in the
last visit was used for those who visited more than once
during the specified period. Data cleaning was undertaken
and three population samples were drawn at different levels
for different purposes. (Figure 1) Sample 1 was used to
study the vitamin D testing pattern of the centre, while
sample 2 was used to associate the country of origin lati-
tude to the post migration VDD. The association between
VDD and the FRS was assessed using the third sample.
Steps were taken to eliminate the effect of supplementation
on vitamin D test results in sample 2 and 3 (Figure 1).
Data analysis
The correction method (“log (vit D) + [overall mean log
(vit D) – mean (log vit D) sampled in same month])”
described by Tomson et al. [23] was used to adjust for
seasonal variation of the vitamin D levels in the cohort.
Serum vitamin D (25(OH) D) level < 50 nmol/L was
considered as deficient. Data was summarised using
descriptive statistics. Log binomial regression method
was undertaken to test the association between VDD,
cardiovascular risk factors, cardiovascular risk score,
and the zone of origin of the migrants. Data were analysed
using IBM SPSS version 21. The study was approved by
the Monash University Ethics Committee (CF12/3788 –
2012001835).
Results
Vitamin D testing pattern of the community medical
centre (sample 1)
The total population (of whom 59% were migrants) was
used to examine the vitamin D testing pattern of thecentre. Data presented in Table 1 suggest that, after con-
trolling for age and gender, the centre has given higher
priority in testing vitamin D levels in migrants from
zone 1 and 2, those who are middle-aged, females, and
those with diabetes, or osteoarthritis.
Association between pre-migration latitude and
post-migration VDD (sample 2)
Further analysis using a subset of the cohort (sample 2)
was used to examine the associations between pre-
migration latitude and VDD, eliminating those using
vitamin D supplements. VDD in migrants from three
identified pre-migration zones were compared to those
born in Australia. As shown in Table 2, migrants from
Zone 1 (sufficient Vitamin D production year round)
were approximately 1.5 times, and those from Zone 2
(insufficient Vitamin D production at least one month
per year) were almost 1.2 times, more likely to be VDD
than Australian-born residents after adjusting for age
and gender. This suggests that the lower latitude, the
higher the prevalence of VDD in migrants relocating to
Australia.
Association of zone of origin with cardiovascular risk
Migrants from Zone 1 showed lower smoking rates and
higher cholesterol/HDL ratios, but were 0.44 likely to
have a >15% risk of developing future (10 year) CHD
events when compared to their Australian-born counter-
parts (Table 3).
Association between VDD and the risk of CHD by
migration status
In those for whom 10-year Framingham risk score could
be calculated, there was no association between VDD and
cardiovascular risk in migrants or non-migrants (Table 4).
Discussion
This study examined vitamin D testing patterns among a
multicultural sample of Australian adults in north-east
Melbourne, Australia and examined whether pre-migration
latitude was a risk factor for vitamin D deficiency and
cardiovascular risk post-migration. Migrants, especially
those from Zone 1 and 2, were more likely to be tested
for vitamin D than their Australian-born counterparts.
However given the criteria set for data extraction by the
audit it cannot be determined to what extent the deci-
sion to test for vitamin D testing is informed by clinical
decisions. It is possible that the preferential vitamin D
testing among migrants is simply driven by practitioners’
perceived risk of VDD among migrant populations.
Current evidence suggests that the cost of vitamin D
testing in Australia has increased from $1.02 million in
2000 to $95.6 million in 2010, representing a 94-fold
increase over a 10-year period [24]. Current Australian
# FRS – Framingham Risk Score
Total attendees from 1st Jan 2010 to 31st Dec 2012 (n=2187)
Migrants-1255 (57.4%), Non-migrants-932(42.6%)
Vitamin D levels not tested (n=901)
Migrants-381 (42.3%), Non-
migrants-520(57.7%)
Vitamin D levels tested (n=1286)
Migrants-874 (68.0%), Non-migrants-412(32.0%)
Not on Vitamin D 
treatment (n=529)
On Vitamin D treatment (n=757)
Vitamin D testing done before 
the vit D supplements (n=661)
Total  (n=1190)
Migrants-800 (67.2%), Non-migrants-390(32.8%)
Vitamin D testing done after the 
commencement of Vit D 
supplements (n=96)
Availability of all the data required for the calculation of 
FRS (n=388)
Migrants-241 (62.1%), Non-migrants-147 (37.9%)
The date difference between vitamin D test and Cholesterol 
test is less than 3 months (n=364)
Migrants-231(63.5%), Non-migrants-133(36.5%)
All the data required for the calculation of FRS#
are not available (n=802)
The date difference between vitamin D test and 








Figure 1 Sampling method.
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risk of VDD, such as elderly and those with darker skin.
Formal guidelines that govern the timing of testing (diag-
nosis) and frequency (monitoring) of vitamin D testing
and VDD treatment are urgently needed [26].
In the present study cohort vitamin D testing was also
more frequently undertaken in middle-aged people,
females and those with chronic disease indicative of a
testing pattern adhering to the high risk approach [27].
This finding is supported by previous analysis of data
from the national health care provider, Medicare
Australia, showing the majority of the vitamin D test
had been performed in middle aged adults (30–64
years) and in females [28].
The findings of this study suggest that those migrating
from a zone where sunlight is sufficient to achieve year-
round vitamin D production (closer to the equator) are
at increased risk of VDD post-migration. Migrants fromZone 1 generally have a darker skin which acts as a bar-
rier for the skin penetration of the UVB rays and may
reduce the production of Vitamin D [29]. Our findings
are consistent with the literature showing the higher risk
of VDD in refugee population who migrated to Australia
from countries closer to the equator [30]. For example,
studies done among immigrants from Africa to Australia
reported a prevalence of VDD as 53% (men 20%, women
74%) [31] compared to the general population, which
was 31% (men 22%, women 39%) [5].
The present study also found that those migrating
from areas with sufficient vitamin D all year to a southern
Australian environment had a lower CHD risk than those
who born in Australia. A study looking at ischemic
heart disease, place of birth and, language, utilizing the
Australian national hospital morbidity database, found
that migrants were at higher risk for cardiovascular dis-
eases [32]. However, the Australian Institute of Health and
Table 2 Vitamin D deficiency and country of birth of the migrants (n = 1190)
Country of birth VDD@ (%) UPR** (95% C.I.) APR** (95% C.I.)#
Born in Australia* 201 (51.5) * *
Zone 1 (Latitude N230 to S230) 357 (75.2) 1.48 (1.32-1.65)*** 1.46 (1.31-1.63)
Zone 2 (Latitude N230 to N480 and > S230) 171 (61.1) 1.17 (1.03-1.34) 1.14 (1.00-1.30)
Zone 3 (Latitude > N480) 21 (46.7) 0.92 (0.65-1.29) 0.91 (0.66-1.25)
@Vitamin D deficiency.
*Reference population.
**UPR – Unadjusted Prevalence Ratio, APR – Adjusted Prevalence Ratio.
***Bold numbers – Statistically significant at 0.05 level.
#Adjusted for Age and Gender.
Table 1 Vitamin D testing pattern (assessed by the prevalence ratios) of the institution (n = 2187) during the specified
period
Vitamin D tested 1287 (58.8%) UPR# (95% C.I.) APR# (95% C.I.)
Migration$
Non-migrant 412 (44.2) * *
Migrant-Zone 1 518 (74.3) 1.68 (1.54-1.82)** 1.65 (1.51-1.79)
Migrant-Zone 2 310 (66.0) 1.51 (1.37-1.65) 1.44 (1.30-1.59)
Migrant-Zone 3 46 (52.3) 1.13 (0.89-1.42) 1.12 (0.89-1.41)
Age groups$$ (Y)
<44 745 (54.6) * *
45-64 363 (64.6) 1.18 (1.09-1.28) 1.16 (1.08-1.24)
>65 178 (68.2) 1.25 (1.13-1.37) 1.15 (0.99-1.26)
Gender$$$
Males 524 (54.4) * *
Females 762 (62.3) 1.14 (1.07-1.23) 1.07 (1.02-1.14)
Employment@
Employed 381 (54.8) * *
Unemployed 905 (60.7) 1.11 (1.02-1.20) 0.99 (0.92-1.07)
Smoker@
No 289 (54.0) *
Yes 997 (60.4) 1.12 (1.02-1.22) 0.99 (0.91-1.07)
Drinker@
No 480 (52.5) *
Yes 806 (63.4) 1.21 (1.12-1.30) 1.02 (0.94-1.10)
Diabetes@
No 1183 (57.5) * *
Yes 103 (80.5) 1.40 (1.27-1.54) 1.30 (1.16-1.45)
CHD@
No 1240 (58.4) * *
Yes 46 (74.2) 1.27 (1.09-1.48) 1.14 (0.98-1.34)
Osteoarthritis@
No 1197 (57.5) * *
Yes 89 (83.2) 1.44 (1.31-1.58) 1.29 (1.17-1.43)
#UPR – Unadjusted Prevalence Ratio, APR – Adjusted Prevalence Ratio.
*Reference category.
**Bold numbers – Statistically significant at 0.05 level.
Adjusted for - $-Age and Gender, $$-Latitude and Gender, $$$-Latitude and Age, @-Latitude, Age and Gender.
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Table 3 Zone of origin and its association with post migration CHD$ risk (n = 364)
Reference group Migrants (n = 231, 63.5%)
Those who born in Australia (n = 133, 36.5%) Zone 1 (n = 119) Zone 2 + 3 (n = 112)
n (%) (Latitude N230 to S300) (Latitude > N230 and > S300)
n (%) APR@ (95% C.I.) n (%) APR (95% C.I.)
Hypertension* (>140/90 mmHg) 22(16.5) 16 (13.4) 0.86 (0.44-1.66) 26 (23.2) 1.50 (0.89-2.52)
Current smoking** 66(49.6) 15(12.6) 0.25 (0.14-0.44)*** 29(25.9) 0.59 (0.41-0.87)
Diabetes** 22 (16.5) 23 (19.3) 1.36 (0.79-2.37) 24 (21.4) 0.98 (0.56-1.73)
Cholesterol** (mmol/L)
% High cholesterol level (>5.5) 51 (38.3) 44 (37.0) 0.91 (0.66-1.26) 37 (33.0) 0.81 (0.56-1.17)
% of HDL (<1.0- men, <1.3-women) 62 (46.6) 58 (48.7) 1.22 (0.94-1.59) 47 (42.0) 1.09 (0.83-1.43)
Cholesterol/HDL ratio >4.5 34(25.6) 43(36.1) 1.64 (1.12-2.40) 32 (28.6) 1.43 (0.95-2.14)
Coronary heart disease** 8(6.0) 2 (1.7) 0.57 (0.12-2.65) 10 (8.9) 1.20 (0.43-3.24)
FRS# >15% 74 (55.6) 29 (24.4) 0.44 (0.31-0.62) 59 (52.7) 0.95 (0.75-1.19)
$CHD – Coronary heart disease.
@APR – Adjusted Prevalence Ratio.
*Adjusted for Age, Gender, Smoking, Diabetes, Cholesterol/HDL ratio, Vitamin D (serum 25(OH) D).
**Adjusted for Age and Gender.
***Bold numbers – Statistically significant at 0.05 level.
#Framingham Risk Score - Adjusted for Vitamin D (serum 25 (OH) D) only as this is a composite index of Age, Gender, Smoking, Diabetes, Cholesterol/HDL ratio,
Hypertension. The cut off level was arbitrarily set at 15 (mean – 16.3 and median – 12.7).
Pre-migration zone 3 (n = 12) was amalgamated to zone 2 due to its small numbers.
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overseas experienced a lower CHD specific mortality rate
compared to those who born in Australia [33-35]. Possible
reasons for this could be the mandatory health checks im-
posed pre-migration by the authorities and/or the genetic
factors. Although Australian immigration, health checks
do not specifically test for CHD [36], it does include a
general health screening. As a result of this healthier indi-
vidual get the opportunity to settle, and this effect has
been termed the “healthy migrant effect” [35]. However if
post-migration, this group are at increased risk of VDD
and its long-term sequel, further research is needed toTable 4 VDD@ as a risk factor for higher 10 year CHD**
risk score (n = 364)
FRS$ >15 (%) UPR# (95% C.I.) P value
Migrants
Zone 1 (n = 119) VDD No 7 (26.9) 1.00*
Yes 22 (23.7) 0.92 (0.44- 1.92) 0.83
Zone 2 (n = 112) VDD No 11 (40.7) 1.00*
Yes 48 (56.5) 1.32 (0.81- 2.14) 0.26
Non-migrants (n = 133)
VDD No 25 (59.5) 1.00*
Yes 49 (53.8) 0.91 (0.66-1.24) 0.53
**Coronary heart disease.
*Reference level.
$Framingham Risk Score - No adjustments were made as FRS is a composite
index and the cut off level was arbitrarily set as 15 (mean – 16.3 and median
– 12.7).
#UPR – Unadjusted Prevalence Ratio.
@VDD – Vitamin D Deficiency.discern what are the key factors driving this increased risk
of VDD, which may include cultural, socioeconomic and
genetic factors.
The prevalence of CHD in Australia has been reported
to be 3.0% (males 4.4%, females 2.3%) [37] and the mean
10-year Framingham cardiovascular risk to be 6.3% [38].
Observational studies have suggested an association
exists between vitamin D status and cardiovascular disease
outcomes [39]. A meta-analysis in 2012 found a linear
inverse association between vitamin D (ranging from
20–60 nmol/L) and cardiovascular disease. They re-
ported a small but significant increase in risk of 1.03
(95% CI 1.00, 1.06) with vitamin D deficiency [13].
While studies suggest an inverse association between
vitamin D and vascular and non-vascular mortality, the
causality is still unclear [23]. The present study found
no association between VDD and cardiovascular risk
as estimated by the Framingham risk score (which is
derived from a set of long established risk factors; age,
sex, plasma cholesterol, blood pressure, diabetes and
smoking status). Weak associations between vitamin D
and both plasma cholesterol and blood pressure have
been suggested by some [40,41], but certainly not all
[42,43], studies. Whether the influence of VDD on cardio-
vascular disease risk might be driven via those traditional
risk factors or other factors remains unclear.
Strength and limitations
The retrospective data collection method used in the
present study was preferred over the prospective data
collection to avoid biasing vitamin D testing pattern of
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examination of cardiovascular risk due to lack of avail-
ability of risk factor data for some patients. Cholesterol
testing within 3 months of vitamin D testing date was
used for analyses. As subcutaneous vitamin D synthesis
depends on the solar ultraviolet B radiation, there were,
as expected, marked seasonal differences [44]. As this
study used vitamin D results collected throughout the
year, a seasonality adjustment was undertaken. While
body mass index (BMI) is an important determinant for
both vitamin D status [45] and CHD [46] it was not
available for a sufficient proportion of the cohort to be
used in the analyses undertaken in this study.
Post-migration duration in Australia is an important
variable which was not available for this cohort. According
to Young [47], the “healthy migrant effect” diminishes in-
crementally with the number of years stay post-migration.
The absence of this data is a limitation in the current
analysis. In addition, migrants were categorised in pre-
migration zones by country of origin. As some larger
countries may belong to more than one zone, this
could lead to a misclassification. Other limitations in-
clude lack of information available for use of full-cover
clothing, and that those attending medical centres may
be different from the general population. Details re-
lated to the laboratory methodology for vitamin D testing
was also unavailable to the audit and is acknowledged
as a limitation. The lack of association between VDD
and Framingham risk seen in the present study should
be interpreted with caution, given the limited sample
size. However the study represents a contemporary
picture of vitamin D testing patterns and cardiovascu-
lar risk in a public health clinic servicing a large migrant
population.
Conclusions
The community based medical centre demonstrated
adherence to a high risk strategy for vitamin D testing,
with higher priority given to migrants, middle aged
adults and females. An increasing risk of VDD in those
who migrated from lower latitudes (closer to the equa-
tor) was observed. However migrants had lower CHD
risk compared to those who born in Australia. This
audit suggests that pre-migration zone may be an
important factor relating to the future risk of CHD
(the lower the latitude of origin the lower the future
CHD risk), and may be due to a low smoking rate seen
among migrants. Zone of origin should be considered
in the development of vitamin D testing guidelines.
We found no evidence of an association between VDD
and CHD risk in this cohort, but given the multifactor-
ial risk and long latency of cardiovascular disease,
longitudinal studies may be required to examine this
further.Recommendations and policy implications
The current study has identified the high prevalence of
vitamin D deficiency in migrant populations classified
according to their pre-migration zones, and its association
with some of the cardiovascular risk factors. In light of the
significant burden of vitamin D deficiency, sun exposure,
vitamin D testing and supplementation guidelines should
consider disadvantaged groups including migrants and
their zone of origin.
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